Fact Check Friday: The myth about there being no negotiation in Medicare Part D looms large. In this week’s Fact Check Friday, we debunk this myth and delve into how large, powerful purchasers negotiate directly with prescription drug manufacturers to secure discounts and rebates under Medicare Part D.
Burden on Patients – Asthma Medicines in Health Exchange Plans: In the latest “Burden on Patients” series, we feature a Q&A with Meryl Bloomrosen, senior vice president, policy, advocacy and research at the Asthma and Allergy Foundation of America to learn about why access to medicines is crucial for patients managing their asthma condition. We also released a new fact sheet that highlights some of the potential barriers exchange patients face to accessing needed asthma treatments.
TPP Should Protect Medical Innovation: The Wall Street Journal and The Washington Post recently editorialized that any deal on the Trans-Pacific Partnership (TPP) must protect the investment in research and development required to bring biologics to market, which is of particular value to America’s patients. Find out more here.
Medicare Monday: Recent research published in the Journal of Health Economics found that Medicare Part D has reduced depressive symptoms among older adults due in large part to greater access to available prescription medicines. Learn more about how Part D coverage has helped patients achieve better health outcomes.
Priscilla VanderVeer Priscilla VanderVeer is a deputy vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Silver Spring, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.